Pharma channel feed

No­var­tis high­lights over­all M&A track record fol­low­ing Mor­phoSys im­pair­ment

6 months ago
Deals

In bid to low­er ARIA-E, Eli Lil­ly tries a dif­fer­ent dos­ing reg­i­men for its Alzheimer's drug

6 months ago
R&D

#HLTH24: GLP-1 com­pound­ing phar­ma­cies took cen­ter stage at dig­i­tal health’s biggest con­fer­ence

6 months ago
FDA+
Health Tech

Up­dat­ed: Pfiz­er’s Covid pill pow­ers guid­ance raise, but short­fall else­where rais­es ques­tions

6 months ago

Cor­rect­ed: Gen­mab lines up T cell en­gager pact with Re­vi­tope

6 months ago
Startups
Deals

No­var­tis takes $800M Mor­phoSys write­down mere months af­ter clos­ing ac­qui­si­tion

6 months ago
Deals
R&D

Pfiz­er’s make-or-break quar­ter

6 months ago
Editor's note

Bi­par­ti­san let­ter ques­tions FDA's 'nar­row' in­ter­pre­ta­tion for pri­or­i­ty re­view vouch­ers

6 months ago
FDA+

Await­ing ex­pand­ed ap­provals, Lil­ly and J&J re­lease late-stage da­ta for Crohn's treat­ments

6 months ago
R&D

BeiGene ex­ec­u­tive re­port­ed­ly un­der in­ves­ti­ga­tion in Chi­na

6 months ago
China

Ab­b­Vie makes $1.4B ac­qui­si­tion of Alzheimer's biotech

6 months ago
Startups
Deals

Hun­gary's Olivér Várhe­lyi read­ies to be EU health com­mis­sion­er, pledg­ing ma­jor phar­ma sup­port

6 months ago
Law

House Re­pub­li­cans push for more trans­paren­cy on gov­ern­ment-fund­ed tri­al da­ta

6 months ago
FDA+

Iterum wins ap­proval for new oral an­tibi­ot­ic for UTIs. Now it wants a part­ner

6 months ago
FDA+

Post-Hoc: No­vo’s obe­si­ty en­e­mies

6 months ago
Editor's note
Manufacturing

Sanofi re­ports sales jump for Bey­for­tus as RSV an­ti­body chal­lenger from Mer­ck nears

6 months ago

Sanofi backs fi­bro­sis biotech Agomab as it rais­es $89M Se­ries D

6 months ago
Financing
Startups

CDC ad­vi­sors de­cline to rec­om­mend RSV shots to younger at-risk adults, af­firm­ing pri­or guid­ance

6 months ago
FDA+

Icon's quar­ter­ly earn­ings hit by biotech and phar­ma pull­back

6 months ago
R&D
Outsourcing

Fac­ing lost re­bates, MGM Re­sorts to stop cov­er­ing GLP-1 weight loss shots

6 months ago
Health Tech

No­vo Nordisk pe­ti­tions FDA to stop semaglu­tide com­pound­ing over safe­ty risks

6 months ago
FDA+

Adults 50 and up should get pneu­mo­coc­cal vac­cine, CDC ad­vi­sors say, in boost to Pfiz­er and Mer­ck

6 months ago
FDA+

Pfiz­er wins ap­proval to ex­pand RSV vac­cine to adults at high­er in­fec­tion risk

6 months ago
FDA+

No­vo Nordisk asks FDA to pro­hib­it semaglu­tide com­pound­ing, fol­low­ing Eli Lil­ly

6 months ago
FDA+
First page Previous page 26272829303132 Next page Last page
A service from the Financial Times